As of mid-2026, trader consensus heavily favors no new pandemic, driven by the absence of any pathogen achieving sustained global transmission despite notable outbreaks such as the Bundibugyo Ebola virus disease in the Democratic Republic of the Congo and Uganda, which prompted a WHO PHEIC declaration but remains regionally contained with thousands of cases. Surveillance from agencies like the CDC and WHO shows no novel respiratory virus or high-transmissibility strain matching historical pandemic thresholds, such as those seen with influenza or coronaviruses, while localized events like hantavirus clusters and measles spikes reflect improved detection rather than uncontrolled spread. Realistic challenges include zoonotic spillovers evolving person-to-person transmission or model uncertainties in emerging threats like avian influenza variants, which could shift dynamics if international mobility accelerates before interventions scale.